TCTR20210219009已完成4 期
Ivermectin mass drug administration to reduce malaria transmission in Surat Thani: a cluster randomized trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 6,356
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 Months 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Thai people, both male and female
- •2. Aged > 6 months for mass blood survey to determine malaria infection
- •3. Aged between 5 - 80 years for ivermectin administration
排除标准
- •For participation in MDA:
- •1. Weighing less than 15 kilograms
- •2. Body Temperature > 37.5 oC
- •3. Not available for follow-up
- •4. Known hypersensitivity or anaphylaxis to Ivermectin
- •5. Known active hepatitis or renal disease
- •6. Pregnant or lactating women or planning to become pregnant during MDA
研究者
相似试验
招募中
4 期
A trial of community wide treatment to reduce scabies in a village setting in northern IndiaSkin - Dermatological conditionsInfection - Other infectious diseasesScabiesACTRN12619001712190The Nossal Institute for Global Health (University of Melbourne)2,200
尚未招募
3 期
Repeat Ivermectin Mass Drug Administrations for MALaria Control II (RIMDAMAL II)MalariaPACTR201907479787308Colorado State University4,700
已完成
3 期
Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria EliminationMalariaNCT03576313London School of Hygiene and Tropical Medicine4,939
已完成
1 期
Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adultsMalariaPACTR201908520097051Centre de Recherches Medicales de Lambarene49
尚未招募
不适用
â??To study the effectiveness of Ivermectin with standard of care treatmentversus standard of care treatment for COVID 19 cases. A Pilot StudyCTRI/2020/04/024858Max Super Speciality Hospital A Unit of Devki Devi Foundation